Comparative Efficacy of Hypertension Management Strategies
International Journal of Angiology · 01.12.2024 · 33 (04) · 297-302
DOI: 10.1055/s-0044-1788068 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Angiology, erschienen am 01.12.2024. Verfasst von Jordan Schneider und 5 weiteren Autor:innen. Beteiligte Einrichtung: Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Hypertension (HTN) is a major cardiovascular risk factor and a significant contributor to disease burden in the United States. Despite therapeutic advances, gaps remain between clinical trials and practice. This study aims to bridge those gaps by evaluating antihypertensive strategies. This was a retrospective analysis of HTN patients seen at a hospital clinic from 2016 to 2022 with 3- and 12-month follow-up appointments. Demographics, history, blood pressure (BP), and medication regimen were recorded. Treatment strategies were categorized as follows: adding medication (AM), increasing dosage (ID), switching medications (SM), dropped medications (DrM), or no change (NC). Changes in systolic blood pressure (SBP) were compared using linear regressions to assess the efficacy of HTN management. Of 873 patient charts reviewed, 332 patients were included. The AM group had an adjusted ∆SBP of −11 mm Hg at 3 months (p < 0.001) and −9 mm Hg at 12 months (p = 0.006). The ID group had an ∆SBP of −8.5 mm Hg at 3 months (p = 0.074) and −7 mm Hg at 12 months (p = 0.3). ∆SBP between the AM and ID groups was not statistically significant (p = 0.8). SM was associated with an ∆SBP of −3 mm Hg at 3 months (p = 0.6) and −3 mm Hg at 12 months (p = 0.7). There are meaningful differences in SBP reduction between antihypertensive medication adjustment strategies. AM had the greatest effect on lowering SBP, with ID having a slightly lesser effect. The difference in ∆SBP between the AM versus ID groups was not significant. While further study with a larger dataset is warranted, our findings highlight trends in the efficacy of HTN management strategies to help guide therapeutic regimens.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.
- Department of Cardiology, Nassau University Medical Center, East Meadow, New York.
- Northwell Health, New Hyde Park, New York.
ORCID-Profile: Jordan Schneider, Peter Wenn, Amgad N Makaryus
Zitieren
APA
Schneider, J., Alvarez-Betancourt, A., Elbaz, J., Wenn, P., Makaryus, A. N., & Zeltser, R. (2024). Comparative Efficacy of Hypertension Management Strategies. International Journal of Angiology, 33(04), 297-302. https://doi.org/10.1055/s-0044-1788068
Vancouver
Schneider J, Alvarez-Betancourt A, Elbaz J, Wenn P, Makaryus AN, Zeltser R. Comparative Efficacy of Hypertension Management Strategies. International Journal of Angiology. 2024;33(04):297-302. doi:10.1055/s-0044-1788068
BibTeX
@article{Schneider2024,
author = {Schneider, Jordan and Alvarez-Betancourt, Alejandro and Elbaz, Joshua and Wenn, Peter and Makaryus, Amgad N and Zeltser, Roman},
title = {Comparative Efficacy of Hypertension Management Strategies},
journal = {International Journal of Angiology},
year = {2024},
volume = {33},
number = {04},
pages = {297--302},
doi = {10.1055/s-0044-1788068}
}
EUVIMED